MA26416A1 - CONTROLLED RELEASE PHARMACEUTICAL PEARLS CONTAINING FUROSEMIDE AND A COMPOSITION MADE WITH SAID PEARLS. - Google Patents

CONTROLLED RELEASE PHARMACEUTICAL PEARLS CONTAINING FUROSEMIDE AND A COMPOSITION MADE WITH SAID PEARLS.

Info

Publication number
MA26416A1
MA26416A1 MA24443A MA24443A MA26416A1 MA 26416 A1 MA26416 A1 MA 26416A1 MA 24443 A MA24443 A MA 24443A MA 24443 A MA24443 A MA 24443A MA 26416 A1 MA26416 A1 MA 26416A1
Authority
MA
Morocco
Prior art keywords
pearls
controlled release
release pharmaceutical
composition made
containing furosemide
Prior art date
Application number
MA24443A
Other languages
French (fr)
Inventor
Hans Arwidsson
Maria Eriksson
Lars Stubberud
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of MA26416A1 publication Critical patent/MA26416A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA24443A 1996-01-05 1996-12-26 CONTROLLED RELEASE PHARMACEUTICAL PEARLS CONTAINING FUROSEMIDE AND A COMPOSITION MADE WITH SAID PEARLS. MA26416A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600046A SE9600046D0 (en) 1996-01-05 1996-01-05 New pharmaceutical formulation

Publications (1)

Publication Number Publication Date
MA26416A1 true MA26416A1 (en) 2004-12-20

Family

ID=20400947

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24443A MA26416A1 (en) 1996-01-05 1996-12-26 CONTROLLED RELEASE PHARMACEUTICAL PEARLS CONTAINING FUROSEMIDE AND A COMPOSITION MADE WITH SAID PEARLS.

Country Status (7)

Country Link
AU (1) AU1323897A (en)
HR (1) HRP970004A2 (en)
MA (1) MA26416A1 (en)
SE (1) SE9600046D0 (en)
TN (1) TNSN97001A1 (en)
WO (1) WO1997025028A1 (en)
ZA (1) ZA9610888B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000025752A1 (en) 1998-11-02 2000-05-11 Church, Marla, J. Multiparticulate modified release composition
FR2796840B1 (en) 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques LOW-DOSE TABLETS AND METHOD OF PREPARATION
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
BRPI0015284B8 (en) 1999-10-29 2021-05-25 Euro Celtique S/A controlled release hydrocodone formulations
KR101045144B1 (en) 2000-10-30 2011-06-30 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
US20030091633A1 (en) * 2001-11-15 2003-05-15 John Kelly Methods and compositions for use of (S)-bisoprolol
IL160095A0 (en) * 2004-01-28 2004-06-20 Yissum Res Dev Co Formulations for poorly soluble drugs
ES2346755T3 (en) * 2004-12-01 2010-10-20 Par Pharmaceuticals, Inc. USE OF MEGESTROL ACETATE TO IMPROVE CARDIAC FUNCTION AND TREATMENT OF CARDIAC INSUFFICIENCY.
WO2009145716A1 (en) * 2008-05-28 2009-12-03 Astrazeneca Ab New pharmaceutical formulation useful in gerd therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production

Also Published As

Publication number Publication date
SE9600046D0 (en) 1996-01-05
WO1997025028A1 (en) 1997-07-17
HRP970004A2 (en) 1998-04-30
TNSN97001A1 (en) 2005-03-15
AU1323897A (en) 1997-08-01
ZA9610888B (en) 1997-07-07

Similar Documents

Publication Publication Date Title
DZ2461A1 (en) New arylkylamine derivatives and pharmaceutical composition containing them.
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
DZ1916A1 (en) New compounds and pharmaceutical compositions containing them.
FR2683146B1 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF THE DRUG SUBSTANCE.
NL194577B (en) Preparation for the long-term and controlled release of medicinal substances.
FR2732967B1 (en) 1-PHENYLPYRAZOLE-3-CARBOXAMIDES SUBSTITUTED, ACTIVE IN NEUROTENSIN, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
BRPI9810519B1 (en) 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical composition comprising the same.
MA26453A1 (en) 6-PHENYLPYRIDYL-2 AMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2805818B1 (en) AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9607851B1 (en) combination and pharmaceutical formulation.
DE69618587D1 (en) CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS
MA26491A1 (en) SELECTIVE COX-2 INHIBITOR COMPOUNDS, ANTI-INFLAMMATORY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
BR9804500B1 (en) amide derivative, said pharmaceutical composition and therapeutic agent.
MA26714A1 (en) NOVEL CHIMIOKINE CCR5 MODULATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26445A1 (en) AZABICYCLIC COMPOUNDS CONDENSED WITH A PYRIDONE CORE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2742751B1 (en) NOVEL TAXOIDS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA26416A1 (en) CONTROLLED RELEASE PHARMACEUTICAL PEARLS CONTAINING FUROSEMIDE AND A COMPOSITION MADE WITH SAID PEARLS.
DE69627792D1 (en) Developer container and developer refill device
DE69732649D1 (en) HETEROARYLSULFONAMIDE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
DE69704060D1 (en) TETRAHYDROISOCHINOLINE DERIVATIVES AND THEIR PHARMACEUTICAL APPLICATION
MA26455A1 (en) PYRROLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2751969B1 (en) CFTR CHANNEL ACTIVATING COMPOUNDS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2732968B1 (en) NOVEL TAXOIDS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69632344D1 (en) TRITER PENDER DERIVATIVES AND DRUGS AGAINST LIVER DISEASES
FR2796380B3 (en) NOVEL AMINOTHIAZOL DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM